Key Data and Outcomes from the GRIFFIN Trial

A summary of updates from the GRIFFIN trial evaluating D-RVd in clinically relevant NDMM patient subgroups.

EP: 1.An Introduction to NDMM: Treatment Options and Patient Risk Stratification

EP: 2.Clinical Insights from the Results of the MASTER Trial

Now Viewing

EP: 3.Key Data and Outcomes from the GRIFFIN Trial

EP: 4.A Practical Approach to Treatment Selection for Patients with NDMM

EP: 5.Optimizing Consolidation and Maintenance Therapy in the NDMM Treatment Landscape

EP: 6.The Future of the NDMM: Comparing Emergent Regimens and Understanding Unmet Needs

EP: 7.Recap: Available Treatment Options in Transplant-Eligible Multiple Myeloma

Recent Videos

Related Content

---

Recap: Available Treatment Options in Transplant-Eligible Multiple Myeloma

ONCOLOGY Staff

July 30th 2023

Article

Experts in the multiple myeloma space discuss recent developments and how to implement new practices in real-world settings.

Related Content

---

Recap: Available Treatment Options in Transplant-Eligible Multiple Myeloma

ONCOLOGY Staff

July 30th 2023

Article

Experts in the multiple myeloma space discuss recent developments and how to implement new practices in real-world settings.